Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > Tirzepatide 2023788-19-2 API
Tirzepatide 2023788-19-2 API buy - large image1
Tirzepatide 2023788-19-2 API buy - image1

Tirzepatide 2023788-19-2 API

2103 Inquiries

Unit Price:

$34-37/KG FOB

Get Latest Price
CAS No.:

2023788-19-2

Content:

99%

Port:

shenzhen

Packaging:

5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg 80mg 100mg/vial,10vials/box

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,D/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
12 days
Qualification:
Main Products:

Tirzepatide,Semaglutide,Retatrutide,MOTS-C,GHK-CU,MT-2

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Tirzepatide is the world’s first GLP1/GIP dual receptor agonist developed by Eli Lilly and Company. It exhibits potent glucoselowering effects and significant weight reduction, represen ting a breakthrough in the treatment of type 2 diabetes and obesity.It improves glucose control by enhancing glucosedependent secretion, suppressing inappropriately elevated glucagon secretion, and delaying gastric emptying. It also reduces food intake and body weight through central effects on appetite and satiety.

    Tirzepatide demonstrates a significantly greater reduction in HbA1c than semaglutide, SGLT2 inhibitors, and metformin. The 15 mg group achieves an average weight loss of 15%–22.5%, with a more pronou nced reduction in visceral fat. GIP mediates bidirectional regulation of glucagon, resulting in a lower risk of hypoglycemia during weight loss in nondiabetic patients. Tirzepatide also improves blood lipids, blood pressure, and fatty liver, and provides potential betacell protection.

    Shop Tirzepatide 2023788-19-2 API-Detailed Image 1 Shop Tirzepatide 2023788-19-2 API-Detailed Image 2 Shop Tirzepatide 2023788-19-2 API-Detailed Image 3


    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Semaglutide,Retatrutide,MOTS-C,GHK-CU,MT-2

    Location:

    203, NO. 88 Zhongxin North Road, Hangzhou Avenue Sub-district, Binhai New Area, Tianjin

    Payment Terms:

    TT against copy of documents,D/P,D/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    12 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

       Our company is a professional enterprise engaged in the chemical industry for many years, specializing in the import and export of chemical raw materials, fine chemicals, industrial additives, and related products.
       With a well-established supply chain system and strict quality control standards, we integrate high-quality manufacturing resources to ensure stable product quality and reliable supply. Our product portfolio covers general chemicals, fine chemicals, rubber and plastic raw materials, water treatment chemicals, and other related categories, serving both domestic and international markets.
       Adhering to the principles of integrity, quality first, and mutual benefit, we strictly control product quality and delivery timelines. We provide comprehensive one-stop foreign trade solutions, including product sourcing, customized selection, logistics coordination, and customs clearance services according to customer requirements.
       Leveraging extensive industry experience and a well-developed global sales network, we are committed to meeting diverse international procurement needs. We aim to build a stable and trustworthy bridge for global chemical trade and establish long-term, sustainable partnerships with clients worldwide.
  • Inquiry History
    2103 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.